Navigation Links
Chongqing Cancer Hospital Becomes First Hospital in Southwest China to Offer Cancer Patients Fast, Precise Treatment Using RapidArc® Radiotherapy from Varian Medical Systems
Date:10/11/2010

BEIJING, and PALO ALTO, Calif., Oct. 11 /PRNewswire/ -- Chongqing Cancer Hospital in Southwest China has become the first treatment center in Southwest China to offer cancer patients a faster, more precise form of image-guided radiotherapy that potentially enables doctors to improve outcomes while extending more advanced care to more patients.  Clinicians at the hospital have used RapidArc® radiotherapy from Varian Medical Systems to treat patients for cancers of the nasopharynx, cervix, breast, and lung.

"RapidArc is a major step forward in cancer treatment," said Dr. Yongzhong Wu, M.D., vice president of the hospital and director of the Department of Radiation Therapy.  "Compared with earlier forms of treatment, like 3-D conformal or even traditional intensity-modulated radiotherapy (IMRT), RapidArc is more precise, and faster, so patients have less disruption of their daily lives."

RapidArc delivers a precise and efficient treatment in a single or multiple arcs of the treatment machine around the patient.  By varying the speed of rotation, the shape of the beam, and the dose delivery rate, doctors can use RapidArc to create finely-shaped dose distributions that closely match the size and shape of the tumor while sparing healthy tissues. Faster treatments allow for greater precision, since there is less chance of patient or tumor movement during treatment delivery.  Shorter treatments also help to improve comfort by reducing the amount of time that patients must be immobilized on the treatment table.

"We recently treated a 50-year-old woman with cervical cancer," said Dr. Wu.  "She came to us with irregular bleeding, abdominal pain, and abdominal distension.  After a month of RapidArc treatments, her condition appeared to improve markedly.  And she appears to have avoided many of the side effects commonly associated with conventional radiotherapy for cervical cancer, such as cystitis, intestinal obstr
'/>"/>

SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Abiraterone Acetate Significantly Improved Overall Survival for Patients with Metastatic Advanced Prostate Cancer
2. New Afatinib (BIBW 2992) Data in Non-Small Cell Lung Cancer Patients Presented at the 2010 ESMO Congress
3. Roche and German Cancer Research Center (DKFZ) Enter Research Agreement to Predict Cervical Cancer
4. 10 Tips for Breast Cancer Screening and Early Detection
5. ACD Wins $3 Million Grant From National Cancer Institute to Develop Its CTCscope™ System for Detection and Molecular Analysis of Circulating Tumor Cells
6. Bexion Pharmaceuticals Continues to Gain Support from National Cancer Institute (NCI)
7. Prostate Cancer Treatment Expert Dr. David Samadi, MD Discusses Study Which Found That Low-Income Men Had High-Risk Prostate Cancer Tumors
8. Alma Lasers Joins the Fight Against Breast Cancer with the Launch of the NEW SopranoXLi
9. Ground Breaking Findings on Understanding Cancer Published in the Current Issue of Science
10. Ekahau Delivers Location Tracking Solution to State-of-the-Art Finnish Cancer Center
11. Botanic Oil Innovations Funds Human Clinical Study Using Non-Toxic Salmonella as Cancer Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 2015  CipherHealth, a leading provider of innovations and ... sent representatives to the Nepalese American Nursing Association to ... nurses to Nepal to aid ... month. In addition to helping fund the travel costs ... for much-needed medical supplies for the mission.  ...
(Date:5/5/2015)... 2015   InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" ... today that it will release its full financial results for ... 11 th before the open, followed by a conference ... and business outlook. Participants should call (888) 243-4451 ... and request the InspireMD call. A live webcast of the ...
(Date:5/5/2015)... 5, 2015  Trovagene, Inc. (NASDAQ:  TROV), a ... financial results for the three months ended March ... quarter, we presented favorable clinical results at ASCO ... demonstrating our Precision Cancer Monitoring platform,s ability to ... and lung cancers," said Antonius Schuh, Ph.D., chief ...
Breaking Medicine Technology:Five Nurses and Medical Supplies En Route to Nepal With Donation Assistance from CipherHealth 2InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 2InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 3Trovagene, Inc. Announces First Quarter 2015 Financial Results 2Trovagene, Inc. Announces First Quarter 2015 Financial Results 3Trovagene, Inc. Announces First Quarter 2015 Financial Results 4Trovagene, Inc. Announces First Quarter 2015 Financial Results 5Trovagene, Inc. Announces First Quarter 2015 Financial Results 6
... 15, 2011 The U.S. Food and Drug Administration approved ... patients undergoing magnetic resonance imaging (MRI) of the central ... Gadavist was approved by the FDA on March ... system, helping to detect and visualize lesions that disrupt ...
... and ALISO VIEJO, Calif., March 15, 2011 ... disease screening, cell/molecular biology and immunological testing for ... an agreement with Ambry Genetics, a global leader ... healthcare and life sciences industries, that will allow ...
Cached Medicine Technology:FDA Approves Gadavist for Central Nervous System Scans 2LABS, Inc. Announces Alliance with Ambry Genetics to Expand Testing Solutions for the Reproductive Health Industry 2
(Date:5/5/2015)... Atlanta, Georgia (PRWEB) May 05, 2015 ... Software of Victoria BC announced the Skedans Sensor ... The platform, for mobile and web app developers, provides ... from airborne and mobile sensors. , The Skedans Sensor ... at the intersection of the Internet of Things, Web ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 This year, ... Medals, four Special Merit Awards, three Gold Medals and ... projects are described as follows: , (1) Grand Prize ... Robotic Mannequin for Fashion Design and Fitting, Principal Investigator: ... , The apparel industry relies very much on the ...
(Date:5/5/2015)... New York, NY (PRWEB) May 05, 2015 ... Marketing Platform that enables businesses to deploy Mobile Engagement ... Constant Contact . ProTexting clients can now leverage ... Marketing reach by collecting and syncing subscribers’ e-mail addresses ... Kassabov says “We have recognized that the growing trend ...
(Date:5/5/2015)... 2015 Rare Genomics Institute ... study aimed at determining how crowdfunding can promote scientific ... international non-profit providing rare disease patients with access to ... scientists and researchers, and help for payment of these ... excited to see how crowdfunding will not only help ...
(Date:5/5/2015)... 2015 On April 8th, 2015, at ... Choices Recovery sponsored Durkin Entertainment’s “RockNRolla” EcoLuxe Lounge, a ... of sustainable product placement in TV and film. ... providers of ecologically sound and socially conscious products and ... event that makes appearances at various awards ceremonies and ...
Breaking Medicine News(10 mins):Health News:Skedans Systems Announces Skedans Sensor Collaboration Platform at AUVSI's Unmanned Systems 2015 in Atlanta 2Health News:PolyU wins top prizes in Geneva’s Invention Expo 2Health News:PolyU wins top prizes in Geneva’s Invention Expo 3Health News:PolyU wins top prizes in Geneva’s Invention Expo 4Health News:PolyU wins top prizes in Geneva’s Invention Expo 5Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 2Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 3Health News:Rare Genomics Institute to Study Impact of Crowdfunding on Rare Diseases 2Health News:Choices Recovery Mishawaka Talks About Overcoming Adversity with Actor Matthew Ziff at the “RockNRolla Movie Awards” EcoLuxe Lounge 2
... Focus is system that regulates blood pressure and fluid ... News) -- New research is shedding some light on ... cause miscarriage and death in pregnant women. , "Preeclampsia ... 10 percent of all pregnancies in the United States," ...
... (FA) is a rare and dangerous disease, new laboratory research ... shows it may lead researchers toward clues in more common ... a study published in the Sept. 11 issue of the ... proteins to DNA damage sites is controlled by replication in ...
... the biggest student drinking problems have so far failed to turn ... in the September issue of the Journal of Studies on ... students, alcohol habits showed little change over a dozen years. In ... two weeks; in 2005, 56 percent said the same. And although ...
... blind and visually impaired often rely on others to provide ... with this method is that it doesn,t give them the ... Lahav of Tel Aviv University,s School of Education and Porter ... to the blind, Dr. Lahav has invented a new software ...
... Administration,s (FDA) recent decision to approve the radioimmunotherapy (RIT) ... lymphoma (NHL). "This is welcome news for ... Ph.D., president of SNM and director of nuclear medicine ... "We,ve known for some time that RIT works extremely ...
... Television journalist Veronica ... and now directs her brother,s story to the White House , ... Los Angeles, CA (PRWeb) September 10, 2009 -- After ... brought the tale of her brother Eric,s tragic battle against health care red tape to ...
Cached Medicine News:Health News:Research Seeks Cause of Preeclampsia 2Health News:Replication at DNA damage sites highlights Fanconi anemia and breast cancer proteins 2Health News:Heavy-drinking colleges showing no improvements 2Health News:Virtual maps for the blind 2Health News:Virtual maps for the blind 3Health News:SNM applauds FDA's decision to approve Zevalin 2Health News:Television Journalist Veronica De La Cruz Brings Her Brother's Story from L.A. to White House in Fight for Health Care Reform 2Health News:Television Journalist Veronica De La Cruz Brings Her Brother's Story from L.A. to White House in Fight for Health Care Reform 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: